+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cocaine Use Disorder Market by Therapeutic Approaches, Medications, Treatment Setting - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967619
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cocaine Use Disorder Market grew from USD 1.32 billion in 2023 to USD 1.39 billion in 2024. It is expected to continue growing at a CAGR of 6.21%, reaching USD 2.01 billion by 2030.

Cocaine Use Disorder (CUD) refers to a pattern of cocaine abuse leading to significant impairment or distress, characterized by an inability to control use, craving, and continuing to use despite negative consequences. The necessity for addressing CUD stems from its profound impact on physical and mental health, including an increased risk of cardiovascular issues, psychiatric complications, and socio-economic ramifications. Applications of market solutions in this area can include rehabilitation programs, medication-assisted therapies, and behavioral therapies focusing on reducing relapse rates and improving patient outcomes. The end-use scope primarily involves healthcare providers, rehabilitation centers, and specialized treatment facilities. Key growth factors influencing the market include the rising prevalence of CUD due to increased drug availability and social acceptance, advancements in treatment protocols, and heightened awareness of addiction as a healthcare priority. Latest opportunities lie in developing personalized medicine approaches, leveraging technology for telemedicine, and expanding comprehensive aftercare programs. For businesses, investing in AI-driven diagnostic tools for early detection and prevention of CUD is promising. Challenges include the stigma associated with addiction treatments, regulatory hurdles in drug approval processes, and the need for more robust long-term efficacy data of existing treatments. Additionally, population heterogeneity and differences in treatment access across regions pose significant limitations. Innovative areas ripe for exploration include the development of non-invasive diagnostic tests, wearable technology for monitoring patients, and exploring psychedelics as potential therapeutic agents in clinical settings. The nature of the market is highly dynamic and requires adaptability, with strategic collaborations between academic, governmental, and private sectors crucial to driving growth. There is a strong need for comprehensive campaigns to educate the public and policymakers, fostering an environment conducive to addressing CUD effectively.

Understanding Market Dynamics in the Cocaine Use Disorder Market

The Cocaine Use Disorder Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing prevalence of cocaine use worldwide
    • Increasing awareness and social acceptance of addiction issues, necessitating the treatments for cocaine use disorders
    • Governmental and private funding for addiction treatment programs
  • Market Restraints
    • Limited availability of specialized healthcare providers and social stigmas associated with cocaine addiction
  • Market Opportunities
    • Innovative medicine approaches utilizing genetic and psychosocial markers to tailor personalized treatments
    • Application of artificial intelligence and machine learning in predicting treatment outcomes and enhancements in patient engagement through digital platforms
  • Market Challenges
    • Regulatory hurdles and variability in treatment effectiveness across populations worldwide

Exploring Porter’s Five Forces for the Cocaine Use Disorder Market

Porter’s Five Forces framework further strengthens the insights of the Cocaine Use Disorder Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cocaine Use Disorder Market

External macro-environmental factors deeply influence the performance of the Cocaine Use Disorder Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cocaine Use Disorder Market

The Cocaine Use Disorder Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cocaine Use Disorder Market

The Cocaine Use Disorder Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cocaine Use Disorder Market

The Cocaine Use Disorder Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cocaine Use Disorder Market, highlighting leading vendors and their innovative profiles. These include Alkermes PLC, Alnylam Pharmaceuticals, Inc., Camurus AB, Indivior PLC, Johnson & Johnson Services, Inc., KemPharm, Inc., Novartis International AG, Orexo AB, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Revive Therapeutics Ltd., Sage Therapeutics, Inc., Shionogi & Co., Ltd., Teva Pharmaceuticals USA, Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Cocaine Use Disorder Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Therapeutic Approaches
    • Behavioral Therapies
    • Cognitive-Behavioral Therapy
    • Contingency Management
    • Medication-Assisted Treatment
    • Motivational Enhancement
  • Medications
    • Anticonvulsants
    • Antidepressants
    • Antipsychotics
    • Psychostimulants
  • Treatment Setting
    • Hospital-Based Treatment Programs
    • Inpatient Rehabilitation Centers
    • Outpatient Rehabilitation Centers
    • Residential Rehabilitation Facilities
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of cocaine use worldwide
5.1.1.2. Increasing awareness and social acceptance of addiction issues, necessitating the treatments for cocaine use disorders
5.1.1.3. Governmental and private funding for addiction treatment programs
5.1.2. Restraints
5.1.2.1. Limited availability of specialized healthcare providers and social stigmas associated with cocaine addiction
5.1.3. Opportunities
5.1.3.1. Innovative medicine approaches utilizing genetic and psychosocial markers to tailor personalized treatments
5.1.3.2. Application of artificial intelligence and machine learning in predicting treatment outcomes and enhancements in patient engagement through digital platforms
5.1.4. Challenges
5.1.4.1. Regulatory hurdles and variability in treatment effectiveness across populations worldwide
5.2. Market Segmentation Analysis
5.2.1. Treatment Setting: Increasing preference for residential rehabilitation facilities
5.2.2. Medications: Need based preference for psychostimulants for treatment of cocaine use disorder
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cocaine Use Disorder Market, by Therapeutic Approaches
6.1. Introduction
6.2. Behavioral Therapies
6.3. Cognitive-Behavioral Therapy
6.4. Contingency Management
6.5. Medication-Assisted Treatment
6.6. Motivational Enhancement
7. Cocaine Use Disorder Market, by Medications
7.1. Introduction
7.2. Anticonvulsants
7.3. Antidepressants
7.4. Antipsychotics
7.5. Psychostimulants
8. Cocaine Use Disorder Market, by Treatment Setting
8.1. Introduction
8.2. Hospital-Based Treatment Programs
8.3. Inpatient Rehabilitation Centers
8.4. Outpatient Rehabilitation Centers
8.5. Residential Rehabilitation Facilities
9. Americas Cocaine Use Disorder Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cocaine Use Disorder Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cocaine Use Disorder Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. ??Scientists Develop a Vaccine For Cocaine
12.3.2. FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. COCAINE USE DISORDER MARKET RESEARCH PROCESS
FIGURE 2. COCAINE USE DISORDER MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COCAINE USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2023 VS 2030 (%)
FIGURE 7. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2023 VS 2030 (%)
FIGURE 9. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2023 VS 2030 (%)
FIGURE 11. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. COCAINE USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. COCAINE USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. COCAINE USE DISORDER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL COCAINE USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. COCAINE USE DISORDER MARKET DYNAMICS
TABLE 7. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY COGNITIVE-BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY CONTINGENCY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATION-ASSISTED TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MOTIVATIONAL ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTIPSYCHOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY PSYCHOSTIMULANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY HOSPITAL-BASED TREATMENT PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY INPATIENT REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY OUTPATIENT REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY RESIDENTIAL REHABILITATION FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 33. CANADA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 34. CANADA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 35. CANADA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 36. MEXICO COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 37. MEXICO COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 38. MEXICO COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 50. CHINA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 51. CHINA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 52. CHINA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 53. INDIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 54. INDIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 55. INDIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 57. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 58. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 59. JAPAN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 60. JAPAN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 61. JAPAN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 63. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 64. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 66. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 67. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 69. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 70. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 72. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 73. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 75. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 76. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 77. THAILAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 78. THAILAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 79. THAILAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 81. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 82. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. DENMARK COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 88. DENMARK COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 89. DENMARK COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 90. EGYPT COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 91. EGYPT COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 92. EGYPT COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 93. FINLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 94. FINLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 95. FINLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 96. FRANCE COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 97. FRANCE COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 98. FRANCE COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 99. GERMANY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 100. GERMANY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 101. GERMANY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 103. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 104. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 105. ITALY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 106. ITALY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 107. ITALY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 109. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 110. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 113. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 114. NORWAY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 115. NORWAY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 116. NORWAY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 117. POLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 118. POLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 119. POLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 120. QATAR COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 121. QATAR COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 122. QATAR COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 128. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 132. SPAIN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 133. SPAIN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 134. SPAIN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 137. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 140. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 141. TURKEY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 142. TURKEY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 143. TURKEY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 150. COCAINE USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
TABLE 151. COCAINE USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cocaine Use Disorder Market, which are profiled in this report, include:
  • Alkermes PLC
  • Alnylam Pharmaceuticals, Inc.
  • Camurus AB
  • Indivior PLC
  • Johnson & Johnson Services, Inc.
  • KemPharm, Inc.
  • Novartis International AG
  • Orexo AB
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Revive Therapeutics Ltd.
  • Sage Therapeutics, Inc.
  • Shionogi & Co., Ltd.
  • Teva Pharmaceuticals USA, Inc.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information